Abstract
Biologists and physicians define drug resistance in different terms (Peters 1970 a), the former being more concerned with the parasite and the latter with the host. In this book the definition of WHO (1965) has been adopted. This states that, in malaria, resistance to drugs is the ability of the parasites to survive and/or multiply despite the administration and absorption of a drug given in doses equal to or higher than those usually recommended but within the limits of tolerance of the host. This definition points out that, while it may apply to any species or stage of malaria parasites, it is most commonly used with reference to the action of blood schizontocides, especially the 4-aminoquinolines when used in the treatment of infections with Plasmodium falciparum. This itself is a reflection of the serious impact made by the recognition of chloroquine resistance in P. falciparum in 1959 and 1960 since, in spite of the well-known problem of resistance to proguanil and pyrimethamine that had appeared in various parts of the world from 1949 onwards, no real attempt had been made to define the problem before 1963 (WHO 1963) and it was only in 1967 that a WHO Scientific Group established criteria by which the level of clinical response could be measured.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams ARD, Seaton DR (1949) Resistance to paludrine developed by a strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 42:314–315
Aderounmu AF, Salako LA, Walker O (1981) Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria: II. correlation of in vitro and in vivo sensitivity. Trans R Soc Trop Med Hyg 75:637–640
Alving AS, Rucker K, Flanagan CL, Carson PE, Schrier SL, Kellermeyer RW, Tralov AR (1959) Observations on primaquine in the prophylaxis and cure of vivax malaria. Proc 6 th int congr trop med malar, Lisbon 5–13 Sep 1958. Vol 7, pp 203–209.
(1959) Anais Inst Med Trop 16:Suppl.II
Armstrong JC, Asfaha W, Palmer TT (1976) Chloroquine sensitivity of Plasmodium falciparum in Ethiopia, I. Results of an in vivo test. Am J Trop Med Hyg 25:2–9
Arnold J, Alving AS, Clayman CB (1961) Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg 55:345–350
Aronsson B, Bengtsson E, Björkman A, Pehrson PI, Rombo L, Wahlgren M (1981) Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol 75:367–373
Avery Jones S (1954) Resistance of P. falciparum and P. malariae to pyrimethamine (Dara-prim) following mass treatment with this drug. A preliminary note. East Afr Med J 31:47–49
Avery Jones S (1958) Mass treatment with pyrimethamine: a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya, Sept 1952-Sept 1953. Trans R Soc Trop Med Hyg 52:547–561
Black F, Bygbjerg I, Effersøe P, Gomme G, Jepsen S, Jensen GA (1981) RIII Fansidar resistant falciparum malaria acquired in Southeast Asia. Trans R Soc Trop Med Hyg 75:715–716
Black RH (1958) Results of the clinical use of primaquine for the eradication of relapsing vivax malaria of south-west Pacific origin. Australas Ann Med 7:259
Black RH (1973) Malaria in the Australian army in South Vietnam: successful use of a proguanil-dapsone combination for chemoprophylaxis of chloroquine-resistant falciparum malaria. Med J Aust 1:1265–1270
Brohult J, Hedman P, Rombo L, Sirleaf V, Bengtsson E (1979) Habits of malaria chemoprophylaxis and an analysis of breakdowns in a West African mining town. Ann Trop Med Parasitol 73:327–331
Bruce-Chwatt LJ, Peters W (1979) Chloroquine-resistant Plasmodium falciparum in Africa. Br Med J II: 1374–1375
Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer W (1981) Chemotherapy of malaria, 2nd edn. WHO, Geneva
Burgess RW, Young MD (1959) The development of pyrimethamine resistance by Plasmodium falciparum. Bull WHO 20:37–46
Campbell CC, Collins WE, Chin W, Teutsch SM, Moss DM (1979) Chloroquine-resistant Plasmodium falciparum from East Africa. Lancet II: 1151–1154
Charoenlarp P, Harinasuta T (1973) Relapses of vivax malaria after a conventional course of primaquine and chloroquine: report of two cases. Southeast Asian J Trop Med Public Health 4:135–137
Chaudhuri RN, Chaudhuri MN (1949) Falciparum infection refractory to Paludrine. Indian J Malariol 3:365–369
Chongsuphajaisiddhi T, Subchareon A, Puangpartk S, Harinasuta T (1979) Treatment of falciparum malaria in Thai children. Southeast Asian J Trop Med Public Health 10:132–137
Clyde DF, McCarthy VC (1977) Radical cure of Chesson strain vivax malaria in man by seven, not 14, days of treatment with primaquine. Am J Trop Med Hyg 26:562–563
Clyde DF, Shute GT (1959) Survival of pyrimethamine-resistant Plasmodium falciparum. Trans R Soc Trop Med Hyg 53:170–172
Coatney GR, Myatt AV, Hernandez T, Jeffrey GM, Cooper WC (1952) Studies on the compound 50–63. Trans R Soc Trop Med Hyg 46:496–508
Colwell EJ, Phintuyothin P, Sadudee N, Benjapong W, Neoypatimandondh S (1972) Evaluation of an in vitro technique for detecting chloroquine-resistant falciparum malaria in Thailand. Am J Trop Med Hyg 21:6–12
Contacos PG, Coatney GR, Collins WE, Briesch PE, Jeter MH (1973) Five-day primaquine therapy: an evaluation of radical curative activity against vivax malaria infection. Am J Trop Med Hyg 22:693–695
Couto M (1908) Les injections endo-veineuses du bleu de méthylène dans le paludisme. Bull Soc Pathol Exot 1:292–295
Covell G, Nicol WD, Shute PG, Maryon M (1949) Studies on a West African strain of Plasmodium falciparum, II. The efficacy of paludrine (Proguanil) as a therapeutic agent. Trans R Soc Trop Med Hyg 42:465–476
Dennis DT, Doberstyn EB, Sissay A, Tesfai GK (1974) Chloroquine tolerance of Ethiopian strains of P. falciparum. Trans R Soc Trop Med Hyg 68:241–245
Dixon KE, Williams RG, Ponsupat T, Pitaktong U, Phintuyothin P (1982) A comparative trial of mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fan-sidar. Trans R Soc Trop Med Hyg 76:664–667
Dodge JS, (1967) Malaria chemoprophylaxis in four schools in Kaduna, Northern Nigeria. West Afr Med J 16:55–58
Ebisawa I, Muto T, Tanabe S (1979) Chemotherapy of falciparum malaria: regional differences in responsiveness to treatment. Jpn J Exp Med 49:405–412
Eichenlaub D, Pohle HD (1980) Ein Fall von Falciparum-Malaria mit Chloroquine-Resi-stenz (RI) von den ostafrikanischen Komoren-Inseln. Infection 8:90–91
Eke RE (1979) Possible chloroquine-resistant Plasmodium falciparum in Nigeria. Am J Trop Med Hyg 28:1074–1075
Eppes RB, McNamara JV, DeGowin RL, Carson PE, Powell RD (1967) Chloroquine-resistant Plasmodium falciparum: protective and hemolytic effects of 4,4′-diaminodi-phenylsulfone (DDS) administered daily together with weekly chloroquine and primaquine. Milit Med 132:163–175
Fairley NH (1946) Researches on Paludrine (M 4888) in malaria: an experimental investigation undertaken by the LHQ Medical Research Unit (AIF), Cairns, Australia. Trans R Soc Trop Med Hyg 40:105–151
Field JW, Edeson JFB (1949) Paludrine-resistant falciparum malaria. Trans R Soc Trop Med Hyg 43:233–236
Fogh S, Jepsen S, Effersøe P (1979) Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Trans R Soc Trop Med Hyg 73:228–229
Genther CS, Smith CC (1977) Antifolate studies: activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine-resistant strains of folate-requiring bacteria and Escherichia coli. J Med Chem 20:237–243
Glew RH, Collins WE, Miller LH (1978) Selection of increased quinine resistance in Plasmodium falciparum in Aotus monkeys. Am J Trop Med Hyg 27:9–13
Guha AK, Roy JR, Das S, Roy RG, Pattanayak S (1979) Results of chloroquine sensitivity tests in Plasmodium falciparum in Orissa State. Indian J Mes Res [Suppl] 70:40–47
Gunther CEM, Fraser NM, Wright WG (1952) Proguanil and malaria among non-tolerant New Guinea natives. Trans R Soc Trop Med Hyg 46:185–190
Harinasuta T, Migasen S, Boonag D (1962) Chloroquine resistance in Plasmodium falciparum in Thailand. UNESCO 1st regional symposium on scientific knowledge of tropical parasites. 5–9 Nov. 1962, University of Singapore, Singapore, pp 148–153
Harinasuta T, Gilles HM, Sandosham AA (1976) Malaria in Southeast Asia. Southeast Asian J Trop Med Public Health 7:641–678
Howells RE, Peters W, Fullard J (1970) The chemotherapy of rodent malaria, XIII. Fine structural changes observed in the erythrocytic stages of Plasmodium berghei berghei following exposure to primaquine and menoctone. Ann Trop Med Parasitol 64:203–207
Jaroonvesama N, Harinasuta T, Muangmanee L (1974) Recrudescence, poor response or resistance to quinine of falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 5:504–509
Kean BH (1979) Chloroquine-resistant falciparum malaria from Africa. JAMA 241:395
Knight DJ, Williamson P (1980) The antimalarial activity of N-benzyl oxydihydrotriazines, II. The development of resistance to clociguanil (BRL 50216) and cycloguanil by P. berghei. Ann Trop Med Parasitol 74:407–413
Knight DJ, Williamson P (1982) The antimalarial activity of N-benzyl oxydihydrotriazines, IV. The development of resistance to BRL 6231 [4,6-diamino-1,2–2,2-dimethyl-1-(2,4,5,trichloropropyloxy)-1,3,5,-triazine hydrochloride] by P. berghei. Ibid 76:9–14
Knight DJ, Mamalis P, Peters W (1982) The antimalarial activity of N-benzyl oxydihydrotriazines, III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5-trichloro-propyloxy)- 1,3,5,-triazine-hydrobromide (BRL 51084) and hydrochloride (BRL 6231). Ann Trop Med Parasitol 76:1–7
Kouznetsov RL, Rooney W, Wernsdorfer W, El Gaddal AA, Payne D, Abdalla RE (1979) Assessment of the sensitivity of Plasmodium falciparum to antimalarial drugs at Sennar, Sudan: use of the in vitro microtechnique and the in vivo method. WHO/MAL/79.910. WHO Cyclostyled Report, Geneva
Kouznetsov RL, Rooney W, Wernsdorfer WH, El Gaddal AA, Payne D, Abdalla RE (1980) Use of the in vitro microtechnique for the assessment of drug sensitivity of Plasmodium falciparum in Sennar, Sudan. Bull WHO 58:785–789
Krotoski WA, Krotoski DM, Garnham PCC, Bray RS, Killick-Kendrick R, Draper CC, Targett GAT, Guy MW (1980) Relapses in primate malaria: discovery of two populations of exoerythrocytic stages: preliminary note. Br Med J 1:153–154
Laing ABG (1974) Studies on the chemotherapy of malaria, III. Treatment of falciparum malaria in the Gambia, with BRL 50216 [4,6-diamino-(3,4-dichlorobenzyloxy)-1,2,di-hydro-2,2-dimethyl -1,3,5,-triazine hydrochloride] alone and in combination with sul-phonamides. Trans R Soc Trop Med Hyg 68:133–138
Lourie EM, Seaton DR (1949) Resistance to paludrine developed by a strain of Plasmodium vivax. Trans R Soc Trop Med Hyg 42:315
Maberti S (1960) Desarrollo de resistencia a la pirimetamina: presentacion de 15 cases estudiados en Trujilo, Venezuela. Arch Venez Med Trop Parasitol Med 3:239–259
McGregor IA, Smith DA (1952) Daraprim in treatment of malaria: a study of its effects in falciparum and quartan infections in West Africa. Br Med J I:730–734
McNamara JV, Rieckmann KH, Frischer H, Stockert TA, Carson PE, Powell RD (1967) Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparum. Ann Trop Med Parasitol 61:386–395
Merkli B, Peters W (1976) A comparison of two different methods for the selection of primaquine resistance in Plasmodium berghei berghei. Ann Trop Med Parasitol 70:473–474
Migasena S, Bunnag D, Harinasuta T (1980) A case of P. falciparum malaria in Thailand apparently resistant to quinine. Ann Trop Med Parasitol 74:243–244
Moore DV, Lanier JE (1961) Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 10:5–9
Morbidity Mortality Weekly Report (1978) Chloroquine-resistant malaria acquired in Kenya and Tanzania. Denmark, Georgia, New York, No 47, 27:463–464
Nicol BM (1953) Use and effectiveness of antimalarial drugs: experience of non-native resident populations of Nigeria, West Africa. Br Med J II: 177–180
Nguyen-Dinh P, Trager W (1978) Chloroquine resistance produced in vitro in an African strain of human malaria. Science 200:1397–1398
Nocht B, Werner H (1910) Beobachtungen über relative Chininresistenz bei Malaria aus Brasilien. Dtsch Med Wochenschr 36:1557–1560
Orner AHS (1978) Response of Plasmodium falciparum in Sudan to oral chloroquine. Am J Trop Med Hyg 27:853–857
Palmer TT, Townley LB, Yigzaw M, Armstrong JC (1976) Chloroquine sensitivity of Plasmodium falciparum in Ethiopia, II. Results of an in vitro test. Am J Trop Med Hyg 25:10–13
Pearlman EJ, Doberstyn EB, Sudsok S, Thiemanum W, Kennedy R, Canfield CJ (1980) Chemosuppressive field trials in Thailand IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142490, a 4-quinoline-methanol). Am J Trop Med Hyg 29:1131–1137
Peters W (1965) Drug resistance in Plasmodium berghei, Vincke and Lips, 1948, I. Chloroquine resistance. Exp Parasitol 17:80–89
Peters W (1969) Drug resistance in malaria: a perspective. Trans R Soc Trop Med Hyg 63:25–45
Peters W (1970 a) Chemotherapy and drug resistance in malaria. Academic, London
Peters W (1970 b) A new type of antimalarial drug potentiation. Trans R Soc Trop Med Hyg 64:462–464
Peters W (1974) Recent advances in antimalarial chemotherapy and drug resistance. Adv Parasitol 12:69–114
Peters W (1980) Chemotherapy of malaria. In: Kreier JP (ed) Malaria, vol 1. Academic, New York, pp 145–283
Peters W, Porter M (1976) The chemotherapy of rodent malaria, XXVI. The potential value of WR 122455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites. Ann Trop Med Parasitol 70:271–281
Peters W, Portus JH, Robinson BL (1973) The chemotherapy of rodent malaria, XVII. Dynamics of drug resistance, Part 3: influence of drug combinations on the development of resistance to chloroquine in P. berghei. Ann Trop Med Parasitol 67:143–154
Peters W, Portus J, Robinson BL (1975) The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol 69:155–171
Peters W, Portus JH, Robinson BL (1977) The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142490). Ann Trop Med Parasitol 71:419–427
Peters W, Chance ML, Lissner R, Momen H, Warhurst DC (1978) The chemotherapy of rodent malaria, XXX. The enigmas of the “NS Lines” of P. berghei. Ann Trop Med Parasitol 72:23–36
Petterson T, Kyrönseppä H, Pitkänen T (1981) Chloroquine-resistant falciparum malaria from East Africa. Trans R Soc Trop Med Hyg 75:112–113
Powell RD (1965) The effect of 6-methoxy-8-(5′-propylaminoamylamino)-quinoline phosphate against the asexual erythrocytic forms of a strain of chloroquine-resistant Plasmodium falciparum from Thailand. Bull WHO 32:591–593
Powell RD, Brewer GJ, Alving AS, Millar JW (1964) Studies on a strain of chloroquine-resistant Plasmodium falciparum from Thailand. Bull WHO 30:29–44
Ramkaran AE, Peters W (1969) Infectivity of chloroquine-resistant Plasmodium berghei to Anopheles stephensi enhanced by chloroquine. Nature 223:635–636
Ray AP, Parkinson AD, Black RH (1979) Experimental studies on the effect of proguanil and dapsone against chloroquine-resistant Plasmodium herghei (ANKA) in white mice. Ann Trop Med Hyg 73:19–22
Rieckmann KH (1971) Drug potentiation against pre-erythrocytic stages of Plasmodium falciparum. Trans R Soc Trop Med Hyg 65:533–535
Rieckmann KH (1973) Data in Table 5. In: WHO (1973)
Rieckmann KH, McNamara JV, Frischer H, Stocken TA, Carson PE, Powell RD (1968 a) Effects of chloroquine, quinine, and cycloguanil upon maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg 17:661–671
Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, Powell RD (1968 b) Gametocytocidal and sporontocidal effects of primaquine and sulfadiazine with pyrimethamine in a chloroquine-resistant strain of P. falciparum. Bull WHO 38:625–632
Rieckmann KH, Campbell GH, Sax LJ, Mrema JE (1978) Drug sensitivity of Plasmodium falciparum: an in vitro technique. Lancet I:22–23
Rosario VE, Walliker D, Hall R, Beale GH (1978) Persistence of drug-resistant malaria parasites. Lancet I:185–187
Roy RG, Chakrapani KP, Dhinagaran D, Sitaraman NL, Ghosh RB (1977) Efficacy of 5-day radical treatment of P. vivax infection in Tamil Nadu. Indian J Med Res 65:652–656
Rozman RS, Canfield CJ (1979) New experimental antimalarial drugs. Adv Pharmacol Chemother 16:1–43
Ryley JF, Peters W (1970) The antimalarial activity of some quinoline esters. Ann Trop Med Parasitol 64:209–222
Schmidt LH (1973) Infections with Plasmodium falciparum and Plasmodium vivax in the owl monkey: model systems for basic biological and chemotherapeutic studies. Trans R Soc Trop Med Hyg 67:446–474
Schmidt LH (1979) Studies on the 2,4-diamino-6-substituted quinazolines, III. The capacity of sulfadiazine to enhance the activities of WR 158122 and WR 159412 against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys. Am J Trop Med Hyg 28:808–818
Schneider J, Decourt P, Méchali D (1948) Nouveaux médicaments du paludisme-étude comparée de leur activité dans le traitement curatif et en prophylaxie. Proc 4 th int congr trop med malar, 10–18 May 1948, (Washington) I, pp 756–775. Available from: Department of State, Washington, DC
Sucharit P, Eamsobhana P (1980) In vitro response of Plasmodium falciparum in Thailand to antimalarial drugs. Ann Trop Med Hyg 74:11–15
Sucharit P, Harinasuta T, Chongsuphajaisiddhi T, Tongprasoeth N, Kasemsuth R (1977) In vivo and in vitro studies of chloroquine-resistant malaria in Thailand. Ann Trop Med Parasitol 71:401–405
Thompson PE (1972) Studies on a quinolinemethanol (WR 30090) and on a phenanthrene-methanol (WR 33063) against drug-resistant Plasmodium berghei in mice. Proc Helminthol Soc Wash [Suppl] 39:297–308
Van Goor WT, Lodens JG (1950) Clinical malarial prophylaxis with proguanil. Doc Need Indones Morbis Trop 2:62–81
Warhurst DC, Killick-Kendrick R (1967) Spontaneous resistance to chloroquine in a strain of rodent malaria (Plasmodium berghei yoelii). Nature 213:1048–1049
Wernsdorfer WH (1980) Field evaluation of drug resistance in malaria. In vitro micro-test. Acta Trop 37:222–227
Wernsdorfer WH, Kouznetsov RL (1980) Drug-resistant malaria — occurrence, control, and surveillance. Bull WHO 58:341–352
Whiteside EF (1962) Interactions between drugs, trypanosomes, and cattle in the field. In: Goodwin LG, Nimmo-Smith RH (eds) Drugs, parasites, and hosts. Churchill, London, pp 116–141
WHO (1963) Terminology of malaria and of malaria eradication. Report of a Drafting Committee. WHO, Geneva
WHO (1965) Resistance of malaria parasites to drugs. Report of a WHO Scientific Group. WHO Tech Rep Ser No. 296
WHO (1967) Chemotherapy of malaria. WHO Rep Ser No. 375
WHO (1973) Chemotherapy of malaria and resistance to antimalarials. WHO Rep Ser No. 529
Wilkinson RN, Noeypatimanondh S, Gould DJ (1976) Infectivity of falciparum patients for anopheline mosquitoes before and after chloroquine treatment. Trans R Soc Trop Med Hyg 70:306–307
Wilson T (1952) Discussion. In: Symposium on Daraprim. Trans R Soc Trop Med Hyg 46:499–500
Wise DL, Gresser JD, McCormick GJ (1979) Sustained release of a dual antimalarial system. J Pharm Pharmacol 31:210–204
Young MD (1957) Resistance of Plasmodium malariae to pyrimethamine (Daraprim). Am J Trop Med Hyg 6:621–624
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Peters, W. (1984). History and Current Status of Drug Resistance. In: Peters, W., Richards, W.H.G. (eds) Antimalarial Drugs I. Handbook of Experimental Pharmacology, vol 68 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69251-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-69251-2_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69253-6
Online ISBN: 978-3-642-69251-2
eBook Packages: Springer Book Archive